About Lanadelumab
            
            Class: | Monoclonal antibody (C1 esterase inhibitor)  
Use: | Prophylaxis of hereditary angioedema (HAE) attacks in patients aged 12 years and older  
Adult dose: | 300 mg subcutaneously every 2 weeks; may be adjusted to every week based on individual response  
Pediatric dose: | Safety and efficacy not established in patients under 12 years of age  
Side effects: | Injection site reactions, headache, abdominal pain, nausea, diarrhea, fatigue  
Contraindications: | Hypersensitivity to lanadeluma
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (C1 esterase inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Prophylaxis of hereditary angioedema (HAE) attacks in patients aged 12 years and older
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; may be stored at room temperature (up to 25°C or 77°F) for up to 14 days
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: SHIRE PHARMACEUTICALS IRELAND LIMITED, IRELAND
                    
                    
                    Package Size
                    2ml Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 77905.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        300 mg subcutaneously every 2 weeks; may be adjusted to every week based on individual response
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in patients under 12 years of age
                    
                 
                
                
                    
                        Side Effects
                    
                    Injection site reactions, headache, abdominal pain, nausea, diarrhea, fatigue
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to lanadelumab or any component of the formulation
         
        
        
            
                Important Warnings
            
            Risk of hypersensitivity reactions; monitor for signs of anaphylaxis; not for treatment of acute HAE attacks
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.